Integrated molecular characterization of pediatric soft tissue sarcomas: A report from the COG and CCDI molecular characterization initiative. This is an ASCO Meeting Abstract from the 2025 ASCO ...
Association between targeted cancer drug net health benefit and uptake, patient out-of-pocket spending, and total spending. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This ...
MEXICO CITY, Nov. 4, 2025 /PRNewswire/ -- With the firm purpose of strengthening their capabilities in preventing money laundering (AML) and other illicit activities, Mexican banks will implement a ...
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results